MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update May 27, 2026 07:00AM
MediWound to Report First Quarter 2026 Financial Results May 7, 2026 08:00AM
MediWound highlights consensus supporting wound treatment strategy Apr 13, 2026 07:31AM
Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement Apr 13, 2026 07:30AM
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences Apr 7, 2026 07:00AM


Apr 7, 2026 07:00AM MediWound to Present New EscharEx® Data at Leading Wound Care Conferences
Apr 2, 2026 03:26PM MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
Mar 5, 2026 04:30PM MediWound Files Annual Report on Form 20-F
Mar 5, 2026 07:00AM MediWound Reports Fourth Quarter and Full Year 2025 Financial Results
Feb 19, 2026 08:00AM MediWound to Report Fourth Quarter and Full Year 2025 Financial Results
Feb 17, 2026 08:00AM MediWound to Present at Upcoming Investor Conferences
Jan 12, 2026 07:00AM MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference
Dec 10, 2025 07:01AM MediWound reports clinical data on NexoBrid for traumatic tattoos
Dec 10, 2025 07:00AM MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries
Dec 10, 2025 07:00AM MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries
Nov 20, 2025 07:00AM MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Nov 5, 2025 07:30AM MediWound to Report Third Quarter 2025 Financial Results
Nov 5, 2025 07:30AM MediWound to Report Third Quarter 2025 Financial Results
Nov 3, 2025 08:00AM MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®
Oct 11, 2023 06:01AM MediWound (MDWD) Collaborates with 3M (MMM) on EscharEx Phase III Study
Oct 11, 2023 06:00AM MediWound Announces Collaboration with 3M on EscharEx® Phase III Study
Jan 24, 2022 09:25AM Pre-Open Stock Movers 01/24: (EXTN) (KSS) (UL) Higher; (OPK) (MSTR) (MARA) Lower (more...)
Oct 26, 2015 02:16PM Trading Radar for 10/26: Apple (AAPL), Twitter (TWTR), Alibaba (BABA), Comcast (CMCSA), Pfizer (PFE) Report
Feb 4, 2015 10:00AM MediWound Ltd. (Nasdaq: MDWD) to Ring The Nasdaq Stock Market Closing Bell